Medication info
Collyrin Tablet (Choline Alphoscerate)

Collyrin Tablet (Choline Alphoscerate)

Prescription medicationTabletOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
90 tablets/box [10 tablets/PTPX9], 90 tablets/bottle
Approval status
Active

MFDS item code 201604671 · Approved 2016.07.28 · Insurance code 660703220

Summary

Main use
Improvement of cerebrovascular and degenerative organic brain syndromes (including memory impairment and confusion)
Who takes it
Adults
Adult dose
Administer 400 mg of choline alfoscerate orally per dose, 2~3 times daily. The dose may be adjusted as appropriate according to symptoms.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of cerebrovascular and degenerative organic brain syndromes (including memory impairment and confusion)

  • Memory impairment
  • confusion
  • disorientation
  • reduced motivation
  • reduced spontaneity
  • decreased concentration
View approved original text

This medication is effective for secondary symptoms caused by cerebrovascular deficits and degenerative or organic mental syndromes. It alleviates memory impairment and confusion, and helps to improve disorientation and decreased concentration caused by reduced motivation and spontaneity. It is used to enhance the daily living capabilities of patients by improving these symptoms.

How to take

Adult dose

Administer 400 mg of choline alfoscerate orally per dose, 2~3 times daily. The dose may be adjusted as appropriate according to symptoms.

Precautions

This medication should not be used by patients with allergies to this drug or any of its ingredients. Additionally, it is safest for women who are pregnant or may become pregnant to avoid taking this medication. Nausea may occur when taking this medication, which could be due to the action of dopamine in the brain. If such symptoms occur, the dosage of the medication should be reduced. It can affect the digestive system, potentially leading to gastritis or other gastrointestinal disorders, so caution is warranted. Moreover, it may affect the central nervous system, leading to drowsiness, difficulty falling asleep, irritability or agitation, and in severe cases, seizures or excessive motor activity symptoms. This medication should be stored out of reach of children, and transferring the medication to another container should be avoided as it may cause accidents or diminish the quality of the medication.

Side effects

  • area
  • gastritis
  • gastric disease
  • drowsiness
  • insomnia
  • hostility
  • irritability
  • convulsions
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius to ensure the medication's effectiveness.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

90 tablets/box [10 tablets/PTPX9], 90 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.